Skip to main content
Premium Trial:

Request an Annual Quote

ProSanos, Windber Research Institute Collaborate to Study Impact of Lifestyle on Disease

NEW YORK, Sept. 24 - ProSanos and the Windber Research Institute have partnered to study the impact of lifestyle changes on patient response to disease, the organizations said today.


ProSanos, based in La Jolla, Calif., will provide bioinformatics for data integration and disease modeling based on biological samples from Windber, Penn.-based Windber Research Institute.


Financial details of the agreement were not disclosed.


The collaboration will initially focus on the treatment of heart disease, according to the organizations.


Click here for more information.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.